Discovery and Kinetic Profiling of 7‑Aryl-1,2,4-triazolo[4,3‑a]­pyridines: Positive Allosteric Modulators of the Metabotropic Glutamate Receptor 2 von Doornbos, Maarten L. J, Cid, José María, Haubrich, Jordi, Nunes, Alexandro, van de Sande, Jasper W, Vermond, Sophie C, Mulder-Krieger, Thea, Trabanco, Andrés A, Ahnaou, Abdellah, Drinkenburg, Wilhelmus H, Lavreysen, Hilde, Heitman, Laura H, IJzerman, Adriaan P, Tresadern, Gary

Volltext

Impact of allosteric modulation: Exploring the binding kinetics of glutamate and other orthosteric ligands of the metabotropic glutamate receptor 2 von Doornbos, Maarten L.J., Vermond, Sophie C., Lavreysen, Hilde, Tresadern, Gary, IJzerman, Adriaan P., Heitman, Laura H.

Volltext

Covalent Allosteric Probe for the Metabotropic Glutamate Receptor 2: Design, Synthesis, and Pharmacological Characterization von Doornbos, Maarten L. J, Wang, Xuesong, Vermond, Sophie C, Peeters, Luc, Pérez-Benito, Laura, Trabanco, Andrés A, Lavreysen, Hilde, Cid, José María, Heitman, Laura H, Tresadern, Gary, IJzerman, Adriaan P

Volltext

149 In vitro efficacy studies to support engineered T cell therapies von Munnik, Sabrina de, Hazenoot, Monique, Vermond, Sophie, McLaughlin, Rene, Guadagnoli, Marco, Moiset, Gemma, Holt, Sann, Vlaming, Marijn

Volltext

148 Primary or iPSC-derived cell-based cytotoxicity assays to assess potential safety risks of engineered T cell therapies in vitro von Vermond, Sophie, Hazenoot, Monique, McLaughlin, Rene, Munnik, Sabrina de, Guadagnoli, Marco, Moiset, Gemma, Holt, Sanne, Vlaming, Marijn

Volltext

Abstract 922: End-to-end discovery to support the development of safe and efficacious engineered cell therapies von Vousden, Katherine, Holt, Sanne, Vermond, Sophie, Hazenoot, Monique, Ives, Sarah, Youssef, Sawsan, Glanville, Jake

Volltext

Abstract 294: In vitro efficacy studies to support engineered T cell therapies von Holt, Sanne L., Vermond, Sophie, Hazenoot, Monique, McLaughlin, Rene, Guadagnoli, Marco, Vlaming, Marijn

Volltext

Abstract 1373: Primary or iPSC-derived cell-based cytotoxicity assays to assess potential safety risks of engineered T cell therapies in vitro von Holt, Sanne L., Vermond, Sophie, Hazenoot, Monique, McLaughlin, Rene, Guadagnoli, Marco, Vlaming, Marijn

Volltext

Abstract 3232: In vitro cell based cytotoxicity and T cell activation assays to assess safety and efficacy of engineered T cell therapies von Holt, Sanne, Vermond, Sophie, Hazenoot, Monique Hazenoot, Overman, Jeroen, Aarbiou, Jamil Aarbiou, DeGroot, Jeroen DeGroot

Volltext

Abstract 574: Allogenic HER2-CAR T cells overcome intrinsic trastuzumab resistance in vitro and in vivo in a preclinical model of breast cancer von Oswald, Eva, Moiset, Gemma, Lashuk, Kanstantsin, Vermond, Sophie, Hazenoot, Monique, Schüler, Julia

Volltext

Abstract 5576: In vitro efficacy and safety studies to support engineered T cell therapies von Vermond, Sophie, Quist, Benita, de Munnik, Sabrina, Hazenoot, Monique, Avramescu, Madalina, McLaughlin, Rene, Moiset, Gemma, Vlaming, Marijn

Volltext

Abstract 4058: In vitro binding, efficacy and safety studies to support engineered T cell therapies von Vermond, Sophie, Quist, Benita, Hazenoot, Monique, McLaughlin, Rene, Lopez, David Cobeta, Jayanth, Namrata, Verkaar, Folkert, Aziz, Omar, Vlaming, Maria LH, de Munnik, Sabrina, Moiset, Gemma

Volltext

Covalent Allosteric Probe for the Metabotropic Glutamate Receptor 2 : Design, Synthesis, and Pharmacological Characterization von Doornbos, Maarten L. J, Wang, Xuesong, Vermond, Sophie C, Peeters, Luc, Pérez-Benito, Laura, Trabanco, Andrés A, Lavreysen, Hilde, Cid, José María, Heitman, Laura H, Tresadern, Gary, IJzerman, Adriaan P

Volltext bestellen

Covalent Allosteric Probe for the Metabotropic Glutamate Receptor 2 : Design, Synthesis, and Pharmacological Characterization von Doornbos, Maarten L. J, Wang, Xuesong, Vermond, Sophie C, Peeters, Luc, Pérez-Benito, Laura, Trabanco, Andrés A, Lavreysen, Hilde, Cid, José María, Heitman, Laura H, Tresadern, Gary, IJzerman, Adriaan P

Volltext bestellen